Bristol-Myers Squibb will take part in Leerink Partners Immuno-Oncology Roundtable on October 1.
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, in New York. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about the company at 10 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session athttp://investor.bms.com. An archived edition of the session will be available later that day.